{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T05:14:07Z","timestamp":1718169247858},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,8]]},"DOI":"10.7759\/cureus.40156","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T01:36:38Z","timestamp":1686274598000},"source":"Crossref","is-referenced-by-count":1,"title":["A Call to Action: Hypertensive Crises, Non-ST-Elevation Myocardial Infarction (NSTEMI), and Heart Failure in the Early Twenties"],"prefix":"10.7759","author":[{"given":"Stefan","family":"Milutinovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slobodan","family":"Lazarevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miljan","family":"Krstovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2010.71","article-title":"Risk factors promoting hypertensive crises: evidence from a longitudinal study","volume":"23","author":"Saguner AM","year":"2010","unstructured":"Saguner AM, D\u00fcr S, Perrig M, et al.. Risk factors promoting hypertensive crises: evidence from a longitudinal study. Am J Hypertens. 2010, 23:775-80. 10.1038\/ajh.2010.71","journal-title":"Am J Hypertens"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2021.11.016","article-title":"Primary causes of hypertensive crisis","volume":"38","author":"Van Why SK","year":"2022","unstructured":"Van Why SK, Pan CG. Primary causes of hypertensive crisis. Crit Care Clin. 2022, 38:375-91. 10.1016\/j.ccc.2021.11.016","journal-title":"Crit Care Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000008","article-title":"Undiagnosed hypertension among young adults with regular primary care use","volume":"32","author":"Johnson HM","year":"2014","unstructured":"Johnson HM, Thorpe CT, Bartels CM, et al.. Undiagnosed hypertension among young adults with regular primary care use. J Hypertens. 2014, 32:65-74. 10.1097\/HJH.0000000000000008","journal-title":"J Hypertens"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.067","article-title":"Obesity and age of first non-ST-segment elevation myocardial infarction","volume":"52","author":"Madala MC","year":"2008","unstructured":"Madala MC, Franklin BA, Chen AY, et al.. Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008, 52:979-85. 10.1016\/j.jacc.2008.04.067","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195312911.003.0009","article-title":"Obesity and cardiovascular disease","author":"Hu F","year":"2008","unstructured":"Hu F. Obesity and cardiovascular disease. Obesity Epidemiology. Hu F (ed): Oxford University Press, Inc., New York, NY; 2008. 174-95. 10.1093\/acprof:oso\/9780195312911.003.0009"},{"key":"ref6","article-title":"Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity","volume":"11","author":"Henning RJ","year":"2021","unstructured":"Henning RJ. Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity. Am J Cardiovasc Dis. 2021, 11:504-29.","journal-title":"Am J Cardiovasc Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai T","year":"2021","unstructured":"Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021, 320:C375-91. 10.1152\/ajpcell.00379.2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.312321","article-title":"Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation","volume":"126","author":"Mouton AJ","year":"2020","unstructured":"Mouton AJ, Li X, Hall ME, Hall JE. Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation. Circ Res. 2020, 126:789-806. 10.1161\/CIRCRESAHA.119.312321","journal-title":"Circ Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00206.2011","article-title":"Enhanced endothelin-1 system activity with overweight and obesity","volume":"301","author":"Weil BR","year":"2011","unstructured":"Weil BR, Westby CM, Van Guilder GP, Greiner JJ, Stauffer BL, DeSouza CA. Enhanced endothelin-1 system activity with overweight and obesity. Am J Physiol Heart Circ Physiol. 2011, 301:H689-95. 10.1152\/ajpheart.00206.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119752","article-title":"Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin\/angiotensin II crosstalk","volume":"100","author":"Folli F","year":"1997","unstructured":"Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin\/angiotensin II crosstalk. J Clin Invest. 1997, 100:2158-69. 10.1172\/JCI119752","journal-title":"J Clin Invest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032474","article-title":"Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity","volume":"137","author":"Packer M","year":"2018","unstructured":"Packer M. Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity. Circulation. 2018, 137:1614-31. 10.1161\/CIRCULATIONAHA.117.032474","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.104.2.145","article-title":"C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites","volume":"104","author":"Chambers JC","year":"2001","unstructured":"Chambers JC, Eda S, Bassett P, et al.. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. 2001, 104:145-50. 10.1161\/01.cir.104.2.145","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801792","article-title":"The relation of body fat mass and distribution to markers of chronic inflammation","volume":"25","author":"Festa A","year":"2001","unstructured":"Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001, 25:1407-15. 10.1038\/sj.ijo.0801792","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/hc0502.103331","article-title":"Weight loss reduces C-reactive protein levels in obese postmenopausal women","volume":"105","author":"Tchernof A","year":"2002","unstructured":"Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation. 2002, 105:564-9. 10.1161\/hc0502.103331","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/152.10.897","article-title":"Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome","volume":"152","author":"Sakkinen PA","year":"2000","unstructured":"Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol. 2000, 152:897-907. 10.1093\/aje\/152.10.897","journal-title":"Am J Epidemiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s001250100007","article-title":"Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss","volume":"44","author":"Mavri A","year":"2001","unstructured":"Mavri A, Alessi MC, Bastelica D, et al.. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss. Diabetologia. 2001, 44:2025-31. 10.1007\/s001250100007","journal-title":"Diabetologia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-17907","article-title":"Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women","volume":"33","author":"Mertens I","year":"2001","unstructured":"Mertens I, Van der Planken M, Corthouts B, Wauters M, Peiffer F, De Leeuw I, Van Gaal L. Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women. Horm Metab Res. 2001, 33:602-7. 10.1055\/s-2001-17907","journal-title":"Horm Metab Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-7125(05)70211-x","article-title":"C-reactive protein, inflammation, and coronary risk","volume":"84","author":"Morrow DA","year":"2000","unstructured":"Morrow DA, Ridker PM. C-reactive protein, inflammation, and coronary risk. Med Clin North Am. 2000, 84:149-61. 10.1016\/s0025-7125(05)70211-x","journal-title":"Med Clin North Am"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/hh2101.099270","article-title":"Novel clinical markers of vascular wall inflammation","volume":"89","author":"Blake GJ","year":"2001","unstructured":"Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001, 89:763-71. 10.1161\/hh2101.099270","journal-title":"Circ Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000020650.86137.84","article-title":"Obesity, metabolic syndrome, and coronary atherosclerosis","volume":"105","author":"Grundy SM","year":"2002","unstructured":"Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 2002, 105:2696-8. 10.1161\/01.cir.0000020650.86137.84","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6507.20.03361-1","article-title":"Obesity and physical exercise","volume":"46","author":"Celik O","year":"2021","unstructured":"Celik O, Yildiz BO. Obesity and physical exercise. Minerva Endocrinol (Torino). 2021, 46:131-44. 10.23736\/S2724-6507.20.03361-1","journal-title":"Minerva Endocrinol (Torino)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13428","article-title":"Resistance training effectiveness on body composition and body weight outcomes in individuals with overweight and obesity across the lifespan: a systematic review and meta-analysis","volume":"23","author":"Lopez P","year":"2022","unstructured":"Lopez P, Taaffe DR, Galv\u00e3o DA, et al.. Resistance training effectiveness on body composition and body weight outcomes in individuals with overweight and obesity across the lifespan: a systematic review and meta-analysis. Obes Rev. 2022, 23:e13428. 10.1111\/obr.13428","journal-title":"Obes Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.10.009","article-title":"Exercise in the management of obesity","volume":"92","author":"Petridou A","year":"2019","unstructured":"Petridou A, Siopi A, Mougios V. Exercise in the management of obesity. Metabolism. 2019, 92:163-9. 10.1016\/j.metabol.2018.10.009","journal-title":"Metabolism"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.84.s1.03","article-title":"The essential role of exercise in the management of type 2 diabetes","volume":"84","author":"Kirwan JP","year":"2017","unstructured":"Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. Cleve Clin J Med. 2017, 84:S15-21. 10.3949\/ccjm.84.s1.03","journal-title":"Cleve Clin J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu191","article-title":"Exercise and cardiovascular risk in patients with hypertension","volume":"28","author":"Sharman JE","year":"2015","unstructured":"Sharman JE, La Gerche A, Coombes JS. Exercise and cardiovascular risk in patients with hypertension. Am J Hypertens. 2015, 28:147-58. 10.1093\/ajh\/hpu191","journal-title":"Am J Hypertens"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2020.08.018","article-title":"Best practices in the management of overweight and obesity","volume":"105","author":"Tchang BG","year":"2021","unstructured":"Tchang BG, Saunders KH, Igel LI. Best practices in the management of overweight and obesity. Med Clin North Am. 2021, 105:149-74. 10.1016\/j.mcna.2020.08.018","journal-title":"Med Clin North Am"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2021.01.031","article-title":"Improvement of glucose metabolism following rapid weight loss after bariatric surgery and its impact on reduction of visceral abdominal fat versus free fat muscle","volume":"17","author":"Cogollo VJ","year":"2021","unstructured":"Cogollo VJ, Rivera CE, Valera RJ, et al.. Improvement of glucose metabolism following rapid weight loss after bariatric surgery and its impact on reduction of visceral abdominal fat versus free fat muscle. Surg Obes Relat Dis. 2021, 17:933-8. 10.1016\/j.soard.2021.01.031","journal-title":"Surg Obes Relat Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1447","article-title":"Effect of bariatric surgery on adipose tissue glucose metabolism in different depots in patients with or without type 2 diabetes","volume":"39","author":"Dadson P","year":"2016","unstructured":"Dadson P, Landini L, Helmi\u00f6 M, et al.. Effect of bariatric surgery on adipose tissue glucose metabolism in different depots in patients with or without type 2 diabetes. Diabetes Care. 2016, 39:292-9. 10.2337\/dc15-1447","journal-title":"Diabetes Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2021.0359","article-title":"Obesity surgery","volume":"119","author":"Fink J","year":"2022","unstructured":"Fink J, Seifert G, Bl\u00fcher M, Fichtner-Feigl S, Marjanovic G. Obesity surgery. Dtsch Arztebl Int. 2022, 119:70-80. 10.3238\/arztebl.m2021.0359","journal-title":"Dtsch Arztebl Int"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.241","article-title":"Complications of bariatric surgery: what you can expect to see in your GI practice","volume":"112","author":"Schulman AR","year":"2017","unstructured":"Schulman AR, Thompson CC. Complications of bariatric surgery: what you can expect to see in your GI practice. Am J Gastroenterol. 2017, 112:1640-55. 10.1038\/ajg.2017.241","journal-title":"Am J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.164183","article-title":"Endocrine and metabolic complications after bariatric surgery","volume":"21","author":"Jammah AA","year":"2015","unstructured":"Jammah AA. Endocrine and metabolic complications after bariatric surgery. Saudi J Gastroenterol. 2015, 21:269-77. 10.4103\/1319-3767.164183","journal-title":"Saudi J Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2016.01.067","article-title":"Complications of bariatric surgery: presentation and emergency management","volume":"27","author":"Kassir R","year":"2016","unstructured":"Kassir R, Debs T, Blanc P, Gugenheim J, Ben Amor I, Boutet C, Tiffet O. Complications of bariatric surgery: presentation and emergency management. Int J Surg. 2016, 27:77-81. 10.1016\/j.ijsu.2016.01.067","journal-title":"Int J Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142087-a-call-to-action-hypertensive-crises-non-st-elevation-myocardial-infarction-nstemi-and-heart-failure-in-the-early-twenties","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:08Z","timestamp":1707508868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142087-a-call-to-action-hypertensive-crises-non-st-elevation-myocardial-infarction-nstemi-and-heart-failure-in-the-early-twenties"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.40156","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}